Novel Treatment Approaches with mAbs Targeting Amyloid Deposits: Insights from VITAL

A panel of expert oncologists explore novel therapies using monoclonal antibodies designed to target amyloid deposit, highlighting key data from the VITAL study.

Related Keywords

,Transforming Outcomes ,Precision Medicine ,Targeted Therapies ,Treatment Approaches ,Abs Targeting Amyloid Deposits ,Light Chain Amyloidosis ,Al Amyloidosis ,Andromeda ,Daratumumab ,Vital ,Pronto ,Affirm Al ,Nexicart 1 ,Amyloid Deposits ,Cd 38 Directed Monoclonal Antibodies ,Cardiac Involvement ,Mayo Cardiac Staging ,Stem Cell Transplant ,Remission ,Duration Of Therapy ,Diagnosis ,Unmet Needs ,Managing Al Amyloidosis ,Treating Al Amyloidosis ,Nxc 201 ,Cart Therapy ,Amyloidosis Diagnosis ,Prognosis ,Mortality ,